USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -7.79% | -10.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.79% | -10.77% | |||
| Cost of Revenue | 0.78% | -18.67% | |||
| Gross Profit | -10.16% | -8.31% | |||
| SG&A Expenses | -4.33% | -6.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.18% | -9.40% | |||
| Operating Income | -115.84% | -34.11% | |||
| Income Before Tax | 95.75% | -222.21% | |||
| Income Tax Expenses | -32.76% | 6.41% | |||
| Earnings from Continuing Operations | 75.35% | -501.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -79.69% | 1,081.47% | |||
| Net Income | 74.02% | -384.52% | |||
| EBIT | -115.84% | -34.11% | |||
| EBITDA | -60.35% | -24.09% | |||
| EPS Basic | 74.03% | -383.16% | |||
| Normalized Basic EPS | -93.59% | 26.26% | |||
| EPS Diluted | 74.10% | -383.97% | |||
| Normalized Diluted EPS | -93.59% | 26.35% | |||
| Average Basic Shares Outstanding | 0.06% | 0.48% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||